<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB01003</drugbank-id>
  <drugbank-id>APRD00336</drugbank-id>
  <name>Cromoglicic acid</name>
  <description>A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.</description>
  <cas-number>16110-51-3</cas-number>
  <unii>Y0TK0FS77W</unii>
  <average-mass>468.3665</average-mass>
  <monoisotopic-mass>468.069261354</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A1587</ref-id>
        <pubmed-id>8564197</pubmed-id>
        <citation>Heinke S, Szucs G, Norris A, Droogmans G, Nilius B: Inhibition of volume-activated chloride currents in endothelial cells by chromones. Br J Pharmacol. 1995 Aug;115(8):1393-8.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference>Margit Nagy, Lidia Fedina, Rita Balazs, Borbala Barta, Gizella Toth nee Gyarmati, Judit Marczis, Andras Szasz, "Antiasthmatic aerosol preparation of sodium cromoglycate." U.S. Patent US5753208, issued June, 1965.</synthesis-reference>
  <indication>For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.</indication>
  <pharmacodynamics>Cromoglicate or cromolyn (USAN), a synthetic compound, inhibits antigen-induced bronchospasms and, hence, is used to treat asthma and allergic rhinitis. Cromoglicate is used as an ophthalmic solution to treat conjunctivitis and is taken orally to treat systemic mastocytosis and ulcerative colitis.</pharmacodynamics>
  <mechanism-of-action>Cromoglicate inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. Cromoglicate also may reduce the release of inflammatory leukotrienes. Cromoglicate may act by inhibiting calcium influx.</mechanism-of-action>
  <toxicity>Symptoms of overdose include cough, nasal congestion, nausea, sneezing and wheezing.</toxicity>
  <metabolism/>
  <absorption>1%</absorption>
  <half-life>1.3 hours</half-life>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as chromones. These are compounds containing a benzopyran-4-one moiety.</description>
    <direct-parent>Chromones</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organoheterocyclic compounds</superclass>
    <class>Benzopyrans</class>
    <subclass>1-benzopyrans</subclass>
    <alternative-parent>Alkyl aryl ethers</alternative-parent>
    <alternative-parent>Benzenoids</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Dicarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Oxacyclic compounds</alternative-parent>
    <alternative-parent>Pyranones and derivatives</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <alternative-parent>Vinylogous esters</alternative-parent>
    <substituent>Alcohol</substituent>
    <substituent>Alkyl aryl ether</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Chromone</substituent>
    <substituent>Dicarboxylic acid or derivatives</substituent>
    <substituent>Ether</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Oxacycle</substituent>
    <substituent>Pyran</substituent>
    <substituent>Pyranone</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Vinylogous ester</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT000985</drugbank-id>
      <name>Cromoglicate sodium</name>
      <unii>Q2WXR1I0PK</unii>
      <cas-number>15826-37-6</cas-number>
      <inchikey>VLARUOGDXDTHEH-UHFFFAOYSA-L</inchikey>
      <average-mass>512.334</average-mass>
      <monoisotopic-mass>512.03314983</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english" coder="">5-[3-(2-carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid</synonym>
    <synonym language="french" coder="inn">Acide Cromoglicique</synonym>
    <synonym language="spanish" coder="inn">Acido Cromoglicico</synonym>
    <synonym language="latin" coder="inn">Acidum Cromoglicicum</synonym>
    <synonym language="english" coder="">Cromoglicate</synonym>
    <synonym language="english" coder="inn">Cromoglicic acid</synonym>
    <synonym language="english" coder="ban">Cromoglycate</synonym>
    <synonym language="english" coder="">Cromoglycic acid</synonym>
    <synonym language="english" coder="usan">Cromolyn</synonym>
  </synonyms>
  <products>
    <product>
      <name>Allergan Eye Itch Relief</name>
      <labeller>Allergan</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02302721</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anti-allergy Eye Drops</name>
      <labeller>Pendopharm Division Of Pharmascience Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02279967</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Apo-cromolyn Nasal Spray</name>
      <labeller>Apotex Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231390</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-07-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray</dosage-form>
      <strength/>
      <route>Nasal</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Apo-cromolyn Sterules</name>
      <labeller>Apotex Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231431</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Crolom</name>
      <labeller>Bauch &amp; Lomb Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code>24208-300</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-01-30</started-marketing-on>
      <ended-marketing-on>2010-02-06</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074443</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Eye Drops</name>
      <labeller>Pendopharm Division Of Pharmascience Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02009277</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>CVS Health</labeller>
      <ndc-id/>
      <ndc-product-code>59779-075</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-07-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray, metered</dosage-form>
      <strength>5.2 mg/1mL</strength>
      <route>Nasal</route>
      <fda-application-number>ANDA075702</fda-application-number>
      <generic>true</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>37205-223</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-07-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray, metered</dosage-form>
      <strength>5.2 mg/1mL</strength>
      <route>Nasal</route>
      <fda-application-number>ANDA075702</fda-application-number>
      <generic>true</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Pacific Pharma</labeller>
      <ndc-id/>
      <ndc-product-code>60758-458</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-06-11</started-marketing-on>
      <ended-marketing-on>2008-07-19</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA087748</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>King Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>60793-075</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-04-27</started-marketing-on>
      <ended-marketing-on>2008-02-21</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA075088</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Mylan Specialty</labeller>
      <ndc-id/>
      <ndc-product-code>49502-689</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-29</started-marketing-on>
      <ended-marketing-on>2009-06-30</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>20 mg/2mL</strength>
      <route>Respiratory (inhalation)</route>
      <fda-application-number>ANDA074209</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-3555</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-03-24</started-marketing-on>
      <ended-marketing-on>2010-06-30</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>20 mg/2mL</strength>
      <route>Intrabronchial</route>
      <fda-application-number>ANDA075271</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code>0093-1389</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-05-26</started-marketing-on>
      <ended-marketing-on>2016-10-31</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074443</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Major</labeller>
      <ndc-id/>
      <ndc-product-code>0904-5532</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-07-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray, metered</dosage-form>
      <strength>5.2 mg/1mL</strength>
      <route>Nasal</route>
      <fda-application-number>ANDA075702</fda-application-number>
      <generic>true</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Akorn</labeller>
      <ndc-id/>
      <ndc-product-code>17478-291</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-04-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074706</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Actavis Pharma Company</labeller>
      <ndc-id/>
      <ndc-product-code>0472-0752</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-04-02</started-marketing-on>
      <ended-marketing-on>2010-09-30</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>20 mg/2mL</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075067</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Nucare Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68071-3231</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074443</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Prasco, Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>66993-470</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-12-12</started-marketing-on>
      <ended-marketing-on>2018-01-31</ended-marketing-on>
      <dosage-form>Solution, concentrate</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA020479</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Bauch &amp; Lomb Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code>24208-961</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-01-30</started-marketing-on>
      <ended-marketing-on>2018-07-30</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074443</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-3125</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074443</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Micro Labs Limited</labeller>
      <ndc-id/>
      <ndc-product-code>42571-132</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-05-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution, concentrate</dosage-form>
      <strength>100 mg/5mL</strength>
      <route>Oral</route>
      <fda-application-number>ANDA202745</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-3042</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-04-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074706</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Proficient Rx LP</labeller>
      <ndc-id/>
      <ndc-product-code>63187-473</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-05-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074443</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Rising Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>16571-600</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-12-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution, concentrate</dosage-form>
      <strength>100 mg/5mL</strength>
      <route>Oral</route>
      <fda-application-number>ANDA202583</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-1202</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-06-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA075282</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Wallace Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>51525-0470</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-10-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA020479</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Proficient Rx LP</labeller>
      <ndc-id/>
      <ndc-product-code>71205-230</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-06-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA075282</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Proficient Rx LP</labeller>
      <ndc-id/>
      <ndc-product-code>71205-085</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-04-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA074706</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Teva Pharmaceuticals USA, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0172-6406</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-01-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>20 mg/2mL</strength>
      <route>Intrabronchial</route>
      <fda-application-number>ANDA075271</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Woodward Pharma Services Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69784-205</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-10-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>20 mg/2mL</strength>
      <route>Intrabronchial</route>
      <fda-application-number>ANDA209453</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Ailex Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>70556-102</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-10-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>20 mg/2mL</strength>
      <route>Intrabronchial</route>
      <fda-application-number>ANDA209264</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Woodward Pharma Services Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69784-200</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-10-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution, concentrate</dosage-form>
      <strength>100 mg/5mL</strength>
      <route>Oral</route>
      <fda-application-number>ANDA209264</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Ailex Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>70556-101</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-10-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution, concentrate</dosage-form>
      <strength>100 mg/5mL</strength>
      <route>Oral</route>
      <fda-application-number>ANDA209264</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Bausch &amp; Lomb Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code>57782-397</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-07-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray, metered</dosage-form>
      <strength>5.2 mg/1mL</strength>
      <route>Nasal</route>
      <fda-application-number>ANDA075702</fda-application-number>
      <generic>true</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cromolyn Sodium</name>
      <labeller>Sandoz Inc</labeller>
      <ndc-id/>
      <ndc-product-code>61314-237</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-06-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>40 mg/1mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>ANDA075282</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gastrocrom</name>
      <labeller>Celltech Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>53014-678</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-05-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution, concentrate</dosage-form>
      <strength>100 mg/5mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gastrocrom</name>
      <labeller>Jazz Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>18860-678</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-11-01</started-marketing-on>
      <ended-marketing-on>2019-02-28</ended-marketing-on>
      <dosage-form>Solution, concentrate</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA020479</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gastrocrom</name>
      <labeller>MEDA Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>0037-0678</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA020479</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gen-cromoglycate Sterinebs - Liq Inh 1%</name>
      <labeller>Genpharm Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02219468</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-09-10</started-marketing-on>
      <ended-marketing-on>2001-08-03</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gen-cromolyn Nasal Spray</name>
      <labeller>Genpharm Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231326</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-07-08</started-marketing-on>
      <ended-marketing-on>2001-08-03</ended-marketing-on>
      <dosage-form>Aerosol, metered; Solution</dosage-form>
      <strength/>
      <route>Nasal</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Intal</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-1894</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-06-10</started-marketing-on>
      <ended-marketing-on>2009-09-30</ended-marketing-on>
      <dosage-form>Inhalant</dosage-form>
      <strength>1 mg/1</strength>
      <route>Respiratory (inhalation)</route>
      <fda-application-number>NDA018887</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intal</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-2822</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-06-10</started-marketing-on>
      <ended-marketing-on>2009-09-30</ended-marketing-on>
      <dosage-form>Inhalant</dosage-form>
      <strength>1 mg/1</strength>
      <route>Respiratory (inhalation)</route>
      <fda-application-number>NDA018887</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intal</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>60793-010</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-05-28</started-marketing-on>
      <ended-marketing-on>2008-09-18</ended-marketing-on>
      <dosage-form>Inhalant</dosage-form>
      <strength>20 mg/2mL</strength>
      <route>Respiratory (inhalation)</route>
      <fda-application-number>NDA018596</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intal</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>60793-011</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-12-05</started-marketing-on>
      <ended-marketing-on>2009-03-31</ended-marketing-on>
      <dosage-form>Inhalant</dosage-form>
      <strength>1 mg/1</strength>
      <route>Respiratory (inhalation)</route>
      <fda-application-number>NDA018887</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intal Inhaler</name>
      <labeller>Sanofi Aventis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00555649</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>2007-02-28</ended-marketing-on>
      <dosage-form>Aerosol, metered</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Intal Nebulizer 1%</name>
      <labeller>Aventis Pharma Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00534609</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2004-07-30</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Intal Spincaps 20mg</name>
      <labeller>Aventis Pharma Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00261238</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2006-06-09</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Intal Syncroner</name>
      <labeller>Aventis Pharma Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00638641</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2004-07-30</ended-marketing-on>
      <dosage-form>Aerosol, metered</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nalcrom</name>
      <labeller>Sanofi Aventis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00500895</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>NasalCrom</name>
      <labeller>Prestige Brands Holdings, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>52183-199</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray, metered</dosage-form>
      <strength>5.2 mg/1</strength>
      <route>Nasal</route>
      <fda-application-number>ANDA075702</fda-application-number>
      <generic>true</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Novo-cromolyn Nebulizer Solution 1%</name>
      <labeller>Novopharm Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02049082</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2005-08-10</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nu-cromolyn</name>
      <labeller>Nu Pharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231351</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Liquid; Spray</dosage-form>
      <strength/>
      <route>Nasal</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nu-cromolyn Plastic Ampules</name>
      <labeller>Nu Pharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231671</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-12-03</started-marketing-on>
      <ended-marketing-on>2012-09-04</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Opticrom</name>
      <labeller>Allergan</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230621</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-08-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Opticrom Liq 2%</name>
      <labeller>Rhone Poulenc Rorer</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00394300</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-12</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>PMS-sodium Cromoglycate</name>
      <labeller>Pharmascience Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02046113</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Respiratory (inhalation)</route>
      <fda-application-number/>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Rhinaris-CS Anti-allergic Nasal Mist</name>
      <labeller>Pendopharm Division Of Pharmascience Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01950541</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray, metered</dosage-form>
      <strength/>
      <route>Nasal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Rynacrom Solution 2%</name>
      <labeller>Rhone Poulenc Rorer</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00605255</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-12</ended-marketing-on>
      <dosage-form>Aerosol, metered</dosage-form>
      <strength/>
      <route>Nasal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Solu-crom</name>
      <labeller>Sabex Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239657</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-07-01</started-marketing-on>
      <ended-marketing-on>2008-08-07</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vistacrom Eye Ointment 4%</name>
      <labeller>Allergan</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00803561</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-11</ended-marketing-on>
      <dosage-form>Ointment</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vistacrom Liq 2%</name>
      <labeller>Allergan</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00749478</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-14</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Aarane</name>
      <company>Sanofi</company>
    </international-brand>
    <international-brand>
      <name>Allergocrom</name>
      <company>Ursapharm</company>
    </international-brand>
    <international-brand>
      <name>Colimune</name>
      <company>Sanofi</company>
    </international-brand>
    <international-brand>
      <name>Cromo-Comod</name>
      <company>Ursapharm</company>
    </international-brand>
    <international-brand>
      <name>Cromoptic</name>
      <company>Bausch &amp; Lomb</company>
    </international-brand>
    <international-brand>
      <name>Gastrofrenal</name>
      <company>Marvecs Pharma Services</company>
    </international-brand>
    <international-brand>
      <name>Lomudal</name>
      <company>Sanofi</company>
    </international-brand>
    <international-brand>
      <name>Lomusol</name>
      <company>Sanofi</company>
    </international-brand>
    <international-brand>
      <name>Opticron</name>
      <company>Cooper</company>
    </international-brand>
    <international-brand>
      <name>Rynacrom</name>
      <company>Sanofi</company>
    </international-brand>
    <international-brand>
      <name>Vividrin</name>
      <company>Bausch &amp; Lomb</company>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Gastrocrom</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Intal</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Intal</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Crolom</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Intal</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Intal</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Gastrocrom</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Gastrocrom</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>NasalCrom</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Sodium</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Cromolyn Eye Drops</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Rhinaris-CS Anti-allergic Nasal Mist</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Nalcrom</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Opticrom</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Novo-cromolyn Nebulizer Solution 1%</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Opticrom Liq 2%</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Gen-cromoglycate Sterinebs - Liq Inh 1%</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Intal Nebulizer 1%</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Intal Inhaler</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Gen-cromolyn Nasal Spray</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Nu-cromolyn Plastic Ampules</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Rynacrom Solution 2%</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Intal Spincaps 20mg</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Intal Syncroner</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Solu-crom</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Vistacrom Liq 2%</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Vistacrom Eye Ointment 4%</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Anti-allergy Eye Drops</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Allergan Eye Itch Relief</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Apo-cromolyn Sterules</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Nu-cromolyn</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>Apo-cromolyn Nasal Spray</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
    <mixture>
      <name>PMS-sodium Cromoglycate</name>
      <ingredients>Cromoglicic acid</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>3M Health Care</name>
      <url>http://www.3m.com</url>
    </packager>
    <packager>
      <name>Actavis Group</name>
      <url>http://www.actavis.com</url>
    </packager>
    <packager>
      <name>Akorn Inc.</name>
      <url>http://www.akorn.com</url>
    </packager>
    <packager>
      <name>Alcon Laboratories</name>
      <url>http://www.alcon.com</url>
    </packager>
    <packager>
      <name>Amerisource Health Services Corp.</name>
      <url>http://www.amerisourcebergen.com</url>
    </packager>
    <packager>
      <name>Apotex Inc.</name>
      <url>http://www.apotex.com</url>
    </packager>
    <packager>
      <name>Automatic Liquid Packaging Inc.</name>
      <url/>
    </packager>
    <packager>
      <name>AzurPharma Inc.</name>
      <url>http://www.azurpharma.com</url>
    </packager>
    <packager>
      <name>Bausch &amp; Lomb Inc.</name>
      <url>http://www.bausch.com</url>
    </packager>
    <packager>
      <name>Cardinal Health</name>
      <url>http://www.cardinal.com</url>
    </packager>
    <packager>
      <name>Catalent Pharma Solutions</name>
      <url>http://www.catalent.com</url>
    </packager>
    <packager>
      <name>CVS Pharmacy</name>
      <url>http://www.cvs.com</url>
    </packager>
    <packager>
      <name>Dey Pharma LP</name>
      <url>http://www.dey.com</url>
    </packager>
    <packager>
      <name>Dispensing Solutions</name>
      <url>http://www.drxdispensing.com</url>
    </packager>
    <packager>
      <name>Falcon Pharmaceuticals Ltd.</name>
      <url>http://www.falconpharma.com</url>
    </packager>
    <packager>
      <name>Fisons PLC</name>
      <url/>
    </packager>
    <packager>
      <name>Ivax Pharmaceuticals</name>
      <url/>
    </packager>
    <packager>
      <name>King Pharmaceuticals Inc.</name>
      <url>http://www.kingpharm.com</url>
    </packager>
    <packager>
      <name>Lake Erie Medical and Surgical Supply</name>
      <url/>
    </packager>
    <packager>
      <name>Major Pharmaceuticals</name>
      <url>http://www.majorpharmaceuticals.com</url>
    </packager>
    <packager>
      <name>Medisca Inc.</name>
      <url>http://www.medisca.com</url>
    </packager>
    <packager>
      <name>Novex Pharma</name>
      <url/>
    </packager>
    <packager>
      <name>Pacific Pharma Lp</name>
      <url/>
    </packager>
    <packager>
      <name>Pack Pharmaceuticals</name>
      <url>http://www.packpharma.com</url>
    </packager>
    <packager>
      <name>Pharmacia Inc.</name>
      <url>http://www.pharmaciaupjohn.com</url>
    </packager>
    <packager>
      <name>Pharmedix</name>
      <url>http://www.pharmedixrx.com</url>
    </packager>
    <packager>
      <name>Physicians Total Care Inc.</name>
      <url>http://www.physicianstotalcare.com</url>
    </packager>
    <packager>
      <name>Prescript Pharmaceuticals</name>
      <url>http://www.prescript.net</url>
    </packager>
    <packager>
      <name>Rhone Poulenc Rorer Respiratory</name>
      <url/>
    </packager>
    <packager>
      <name>Sanofi-Aventis Inc.</name>
      <url>http://www.sanofi-aventis.com</url>
    </packager>
    <packager>
      <name>Sorter Labs</name>
      <url/>
    </packager>
    <packager>
      <name>Teva Pharmaceutical Industries Ltd.</name>
      <url>http://www.tevapharm.com</url>
    </packager>
    <packager>
      <name>Warrick Pharmaceuticals Corp.</name>
      <url/>
    </packager>
    <packager>
      <name>Wockhardt Ltd.</name>
      <url>http://www.wockhardtin.com</url>
    </packager>
  </packagers>
  <manufacturers>
    <manufacturer generic="false" url="">King pharmaceuticals inc</manufacturer>
    <manufacturer generic="false" url="">Sanofi aventis us llc</manufacturer>
    <manufacturer generic="false" url="">Ucb inc</manufacturer>
    <manufacturer generic="true" url="">Genera pharmaceuticals llc</manufacturer>
    <manufacturer generic="false" url="">Azur pharma international ltd</manufacturer>
    <manufacturer generic="false" url="">Bausch and lomb pharmaceuticals inc</manufacturer>
    <manufacturer generic="true" url="">Akorn inc</manufacturer>
    <manufacturer generic="true" url="">Alcon laboratories inc</manufacturer>
    <manufacturer generic="true" url="">Novex pharma</manufacturer>
    <manufacturer generic="false" url="">Allergan inc</manufacturer>
    <manufacturer generic="true" url="">Actavis mid atlantic llc</manufacturer>
    <manufacturer generic="true" url="">Dey lp</manufacturer>
    <manufacturer generic="true" url="">Pharmascience inc</manufacturer>
    <manufacturer generic="true" url="">Roxane laboratories inc</manufacturer>
    <manufacturer generic="true" url="">Teva parenteral medicines inc</manufacturer>
    <manufacturer generic="true" url="">Watson laboratories inc</manufacturer>
    <manufacturer generic="true" url="">Wockhardt eu operations (swiss) ag</manufacturer>
    <manufacturer generic="true" url="">L perrigo co</manufacturer>
    <manufacturer generic="true" url="">Qpharma llc</manufacturer>
    <manufacturer generic="false" url="">Blacksmith brands inc</manufacturer>
  </manufacturers>
  <prices>
    <price>
      <description>Nalcrom 100 mg Capsule</description>
      <cost currency="USD">1.54</cost>
      <unit>capsule</unit>
    </price>
    <price>
      <description>Cromolyn Sodium 20 mg/2ml Neb. Solution 2ml Plastic Container</description>
      <cost currency="USD">1.73</cost>
      <unit>plastic</unit>
    </price>
    <price>
      <description>Cromolyn 4% eye drops</description>
      <cost currency="USD">3.65</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Gastrocrom 100 mg/5ml Concentrate 5ml Ampule</description>
      <cost currency="USD">3.92</cost>
      <unit>ampule</unit>
    </price>
    <price>
      <description>Crolom 4% eye drops</description>
      <cost currency="USD">4.46</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Intal inhaler</description>
      <cost currency="USD">5.77</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Cromolyn sodium powder</description>
      <cost currency="USD">9.49</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Cromolyn Sodium 4% Solution 10ml Bottle</description>
      <cost currency="USD">38.74</cost>
      <unit>bottle</unit>
    </price>
    <price>
      <description>Introl 75% solution</description>
      <cost currency="USD">0.13</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Pms-Sodium Cromoglycate 1 % Solution</description>
      <cost currency="USD">0.27</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>CVS Pharmacy cromolyn sod nasal solutn</description>
      <cost currency="USD">0.31</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Cromolyn sodium nasal solution</description>
      <cost currency="USD">0.49</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Nasalcrom 4% spray</description>
      <cost currency="USD">0.66</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Gastrocrom 100 mg/5 ml conc</description>
      <cost currency="USD">0.78</cost>
      <unit>ml</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Adrenergics, Inhalants</category>
      <mesh-id/>
    </category>
    <category>
      <category>Agents for Dermatitis, Excluding Corticosteroids</category>
      <mesh-id/>
    </category>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Anti-Allergic Agents</category>
      <mesh-id>D018926</mesh-id>
    </category>
    <category>
      <category>Anti-Asthmatic Agents</category>
      <mesh-id>D018927</mesh-id>
    </category>
    <category>
      <category>Antiallergic Agents, Excl. Corticosteroids</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Benzopyrans</category>
      <mesh-id>D001578</mesh-id>
    </category>
    <category>
      <category>Chromones</category>
      <mesh-id>D002867</mesh-id>
    </category>
    <category>
      <category>Cromolyn Sodium</category>
      <mesh-id>D004205</mesh-id>
    </category>
    <category>
      <category>Decongestants and Antiallergics</category>
      <mesh-id/>
    </category>
    <category>
      <category>Decreased Histamine Release</category>
      <mesh-id/>
    </category>
    <category>
      <category>Dermatologicals</category>
      <mesh-id>D003879</mesh-id>
    </category>
    <category>
      <category>Drugs for Obstructive Airway Diseases</category>
      <mesh-id/>
    </category>
    <category>
      <category>Heterocyclic Compounds, Fused-Ring</category>
      <mesh-id>D000072471</mesh-id>
    </category>
    <category>
      <category>Intestinal Antiinflammatory Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Mast Cell Stabilizers</category>
      <mesh-id/>
    </category>
    <category>
      <category>Mast-cell Stabilizers</category>
      <mesh-id/>
    </category>
    <category>
      <category>Nasal Preparations</category>
      <mesh-id/>
    </category>
    <category>
      <category>Ophthalmologicals</category>
      <mesh-id/>
    </category>
    <category>
      <category>Pyrans</category>
      <mesh-id>D011714</mesh-id>
    </category>
    <category>
      <category>Respiratory System Agents</category>
      <mesh-id>D019141</mesh-id>
    </category>
    <category>
      <category>Sensory Organs</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Spray</form>
      <route>Nasal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution / drops</form>
      <route>Ophthalmic</route>
      <strength>40 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Ophthalmic</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intrabronchial</route>
      <strength>20 mg/2mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Ophthalmic</route>
      <strength>40 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Oral</route>
      <strength>20 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Oral</route>
      <strength>20 mg/2mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Respiratory (inhalation)</route>
      <strength>20 mg/2mL</strength>
    </dosage>
    <dosage>
      <form>Solution, concentrate</form>
      <route>Oral</route>
      <strength>20 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Spray, metered</form>
      <route>Nasal</route>
      <strength>5.2 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>20 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution, concentrate</form>
      <route>Oral</route>
      <strength>100 mg/5mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Respiratory (inhalation)</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Aerosol, metered; solution</form>
      <route>Nasal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Inhalant</form>
      <route>Respiratory (inhalation)</route>
      <strength>1 mg/1</strength>
    </dosage>
    <dosage>
      <form>Inhalant</form>
      <route>Respiratory (inhalation)</route>
      <strength>20 mg/2mL</strength>
    </dosage>
    <dosage>
      <form>Aerosol, metered</form>
      <route>Respiratory (inhalation)</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Respiratory (inhalation)</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Spray, metered</form>
      <route>Nasal</route>
      <strength>5.2 mg/1</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Respiratory (inhalation)</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid; spray</form>
      <route>Nasal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Ophthalmic</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Spray, metered</form>
      <route>Nasal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Aerosol, metered</form>
      <route>Nasal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Ointment</form>
      <route>Ophthalmic</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="R03AK05">
      <level code="R03AK">Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics</level>
      <level code="R03A">ADRENERGICS, INHALANTS</level>
      <level code="R03">DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</level>
      <level code="R">RESPIRATORY SYSTEM</level>
    </atc-code>
    <atc-code code="R03AK04">
      <level code="R03AK">Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics</level>
      <level code="R03A">ADRENERGICS, INHALANTS</level>
      <level code="R03">DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</level>
      <level code="R">RESPIRATORY SYSTEM</level>
    </atc-code>
    <atc-code code="R03BC01">
      <level code="R03BC">Antiallergic agents, excl. corticosteroids</level>
      <level code="R03B">OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS</level>
      <level code="R03">DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</level>
      <level code="R">RESPIRATORY SYSTEM</level>
    </atc-code>
    <atc-code code="R01AC51">
      <level code="R01AC">Antiallergic agents, excl. corticosteroids</level>
      <level code="R01A">DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE</level>
      <level code="R01">NASAL PREPARATIONS</level>
      <level code="R">RESPIRATORY SYSTEM</level>
    </atc-code>
    <atc-code code="S01GX51">
      <level code="S01GX">Other antiallergics</level>
      <level code="S01G">DECONGESTANTS AND ANTIALLERGICS</level>
      <level code="S01">OPHTHALMOLOGICALS</level>
      <level code="S">SENSORY ORGANS</level>
    </atc-code>
    <atc-code code="R01AC01">
      <level code="R01AC">Antiallergic agents, excl. corticosteroids</level>
      <level code="R01A">DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE</level>
      <level code="R01">NASAL PREPARATIONS</level>
      <level code="R">RESPIRATORY SYSTEM</level>
    </atc-code>
    <atc-code code="D11AH03">
      <level code="D11AH">Agents for dermatitis, excluding corticosteroids</level>
      <level code="D11A">OTHER DERMATOLOGICAL PREPARATIONS</level>
      <level code="D11">OTHER DERMATOLOGICAL PREPARATIONS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
    <atc-code code="S01GX01">
      <level code="S01GX">Other antiallergics</level>
      <level code="S01G">DECONGESTANTS AND ANTIALLERGICS</level>
      <level code="S01">OPHTHALMOLOGICALS</level>
      <level code="S">SENSORY ORGANS</level>
    </atc-code>
    <atc-code code="A07EB01">
      <level code="A07EB">Antiallergic agents, excl. corticosteroids</level>
      <level code="A07E">INTESTINAL ANTIINFLAMMATORY AGENTS</level>
      <level code="A07">ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>48:10.32</ahfs-code>
    <ahfs-code>52:02.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB01003.pdf?1265922751</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>1.84</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-4.1</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>3.58e-02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>1.48</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>5-{3-[(2-carboxy-4-oxo-4H-chromen-5-yl)oxy]-2-hydroxypropoxy}-4-oxo-4H-chromene-2-carboxylic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>cromoglicic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>468.3665</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>468.069261354</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C23H16O11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C23H16O11/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>IMZMKUWMOSJXDT-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>165.89</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>114.11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>44.38</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>8</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>1.77</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-3.4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>210 mg/L</value>
      <source/>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>241 dec C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>1.92</value>
      <source>POMONA (1987)</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>1.1</value>
      <source>SANGSTER,J (1993)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>11447</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>59773</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>2882</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46504509</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C06928</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D07753</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>2779</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50440033</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA449138</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP000819</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Cromoglicate</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL428880</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>RxList</resource>
      <url>http://www.rxlist.com/cgi/generic/cromolyn.htm</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000553</id>
      <name>Calcium-activated potassium channel subunit alpha-1</name>
      <organism>Humans</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q12791" source="Swiss-Prot">
        <name>Calcium-activated potassium channel subunit alpha-1</name>
        <general-function>Voltage-gated potassium channel activity</general-function>
        <specific-function>Potassium channel activated by both membrane depolarization or increase in cytosolic Ca(2+) that mediates export of K(+). It is also activated by the concentration of cytosolic Mg(2+). Its activation dampens the excitatory events that elevate the cytosolic Ca(2+) concentration and/or depolarize the cell membrane. It therefore contributes to repolarization of the membrane potential. Plays a key role in controlling excitability in a number of systems, such as regulation of the contraction of smooth muscle, the tuning of hair cells in the cochlea, regulation of transmitter release, and innate immunity. In smooth muscles, its activation by high level of Ca(2+), caused by ryanodine receptors in the sarcoplasmic reticulum, regulates the membrane potential. In cochlea cells, its number and kinetic properties partly determine the characteristic frequency of each hair cell and thereby helps to establish a tonotopic map. Kinetics of KCNMA1 channels are determined by alternative splicing, phosphorylation status and its combination with modulating beta subunits. Highly sensitive to both iberiotoxin (IbTx) and charybdotoxin (CTX).</specific-function>
        <gene-name>KCNMA1</gene-name>
        <locus>10q22.3</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>87-107
179-199
215-235
240-260
265-285
301-321
368-388</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>7.07</theoretical-pi>
        <molecular-weight>137558.115</molecular-weight>
        <chromosome-location>10</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:6284</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>KCNMA1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U13913</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>537439</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>380</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>380</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q12791</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>KCMA1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>BK channel</synonym>
          <synonym>BKCA alpha</synonym>
          <synonym>Calcium-activated potassium channel, subfamily M subunit alpha-1</synonym>
          <synonym>hSlo</synonym>
          <synonym>K(VCA)alpha</synonym>
          <synonym>KCa1.1</synonym>
          <synonym>KCNMA</synonym>
          <synonym>Maxi K channel</synonym>
          <synonym>MaxiK</synonym>
          <synonym>SLO</synonym>
          <synonym>Slo homolog</synonym>
          <synonym>Slo-alpha</synonym>
          <synonym>Slo1</synonym>
          <synonym>Slowpoke homolog</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001104|Calcium-activated potassium channel subunit alpha-1
MANGGGGGGGSSGGGGGGGGSSLRMSSNIHANHLSLDASSSSSSSSSSSSSSSSSSSSSS
VHEPKMDALIIPVTMEVPCDSRGQRMWWAFLASSMVTFFGGLFIILLWRTLKYLWTVCCH
CGGKTKEAQKINNGSSQADGTLKPVDEKEEAVAAEVGWMTSVKDWAGVMISAQTLTGRVL
VVLVFALSIGALVIYFIDSSNPIESCQNFYKDFTLQIDMAFNVFFLLYFGLRFIAANDKL
WFWLEVNSVVDFFTVPPVFVSVYLNRSWLGLRFLRALRLIQFSEILQFLNILKTSNSIKL
VNLLSIFISTWLTAAGFIHLVENSGDPWENFQNNQALTYWECVYLLMVTMSTVGYGDVYA
KTTLGRLFMVFFILGGLAMFASYVPEIIELIGNRKKYGGSYSAVSGRKHIVVCGHITLES
VSNFLKDFLHKDRDDVNVEIVFLHNISPNLELEALFKRHFTQVEFYQGSVLNPHDLARVK
IESADACLILANKYCADPDAEDASNIMRVISIKNYHPKIRIITQMLQYHNKAHLLNIPSW
NWKEGDDAICLAELKLGFIAQSCLAQGLSTMLANLFSMRSFIKIEEDTWQKYYLEGVSNE
MYTEYLSSAFVGLSFPTVCELCFVKLKLLMIAIEYKSANRESRILINPGNHLKIQEGTLG
FFIASDAKEVKRAFFYCKACHDDITDPKRIKKCGCKRPKMSIYKRMRRACCFDCGRSERD
CSCMSGRVRGNVDTLERAFPLSSVSVNDCSTSFRAFEDEQPSTLSPKKKQRNGGMRNSPN
TSPKLMRHDPLLIPGNDQIDNMDSNVKKYDSTGMFHWCAPKEIEKVILTRSEAAMTVLSG
HVVVCIFGDVSSALIGLRNLVMPLRASNFHYHELKHIVFVGSIEYLKREWETLHNFPKVS
ILPGTPLSRADLRAVNINLCDMCVILSANQNNIDDTSLQDKECILASLNIKSMQFDDSIG
VLQANSQGFTPPGMDRSSPDNSPVHGMLRQPSITTGVNIPIITELVNDTNVQFLDQDDDD
DPDTELYLTQPFACGTAFAVSVLDSLMSATYFNDNILTLIRTLVTGGATPELEALIAEEN
ALRGGYSTPQTLANRDRCRVAQLALLDGPFADLGDGGCYGDLFCKALKTYNMLCFGIYRL
RDAHLSTPSQCTKRYVITNPPYEFELVPTDLIFCLMQFDHNAGQSRASLSHSSHSSQSSS
KKSSSVHSIPSTANRQNRPKSRESRDKQKYVQEERL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0021262|Calcium-activated potassium channel subunit alpha-1 (KCNMA1)
ATGGCAAATGGTGGCGGCGGCGGCGGCGGCAGCAGCGGCGGCGGCGGCGGCGGCGGAGGC
AGCAGTCTTAGAATGAGTAGCAATATCCACGCGAACCATCTCAGCCTAGACGCGTCCTCC
TCCTCCTCCTCCTCCTCTTCCTCTTCTTCTTCTTCCTCCTCCTCTTCCTCCTCGTCCTCG
GTCCACGAGCCCAAGATGGATGCGCTCATCATCCCGGTGACCATGGAGGTGCCGTGCGAC
AGCCGGGGCCAACGCATGTGGTGGGCTTTCCTGGCCTCCTCCATGGTGACTTTCTTCGGG
GGCCTCTTCATCATCTTGCTCTGGCGGACGCTCAAGTACCTGTGGACCGTGTGCTGCCAC
TGCGGGGGCAAGACGAAGGAGGCCCAGAAGATTAACAATGGCTCAAGCCAGGCGGATGGC
ACTCTCAAACCAGTGGATGAAAAAGAGGAGGCAGTGGCCGCCGAGGTCGGCTGGATGACC
TCCGTGAAGGACTGGGCGGGGGTGATGATATCCGCCCAGACACTGACTGGCAGAGTCCTG
GTTGTCTTAGTCTTTGCTCTCAGCATCGGTGCACTTGTAATATACTTCATAGATTCATCA
AACCCAATAGAATCCTGCCAGAATTTCTACAAAGATTTCACATTACAGATCGACATGGCT
TTCAACGTGTTCTTCCTTCTCTACTTCGGCTTGCGGTTTATTGCAGCCAACGATAAATTG
TGGTTCTGGCTGGAAGTGAACTCTGTAGTGGATTTCTTCACGGTGCCCCCCGTGTTTGTG
TCTGTGTACTTAAACAGAAGTTGGCTTGGTTTGAGATTTTTAAGAGCTCTGAGACTGATA
CAGTTTTCAGAAATTTTGCAGTTTCTGAATATTCTTAAAACAAGTAATTCCATCAAGCTG
GTGAATCTGCTCTCCATATTTATCAGCACGTGGCTGACTGCAGCCGGGTTCATCCATTTG
GTGGAGAATTCAGGGGACCCATGGGAAAATTTCCAAAACAACCAGGCTCTCACCTACTGG
GAATGTGTCTATTTACTCATGGTCACAATGTCCACCGTTGGTTATGGGGATGTTTATGCA
AAAACCACACTTGGGCGCCTCTTCATGGTCTTCTTCATCCTCGGGGGACTGGCCATGTTT
GCCAGCTACGTCCCTGAAATCATAGAGTTAATAGGAAACCGCAAGAAATACGGGGGCTCC
TATAGTGCGGTTAGTGGAAGAAAGCACATTGTGGTCTGCGGACACATCACTCTGGAGAGT
GTTTCCAACTTCCTGAAGGACTTTCTGCACAAGGACCGGGATGACGTCAATGTGGAGATC
GTTTTTCTTCACAACATCTCCCCCAACCTGGAGCTTGAAGCTCTGTTCAAACGACATTTT
ACTCAGGTGGAATTTTATCAGGGTTCCGTCCTCAATCCACATGATCTTGCAAGAGTCAAG
ATAGAGTCAGCAGATGCATGCCTGATCCTTGCCAACAAGTACTGCGCTGACCCGGATGCG
GAGGATGCCTCGAATATCATGAGAGTAATCTCCATAAAGAACTACCATCCGAAGATAAGA
ATCATCACTCAAATGCTGCAGTATCACAACAAGGCCCATCTGCTAAACATCCCGAGCTGG
AATTGGAAAGAAGGTGATGACGCAATCTGCCTCGCAGAGTTGAAGTTGGGCTTCATAGCC
CAGAGCTGCCTGGCTCAAGGCCTCTCCACCATGCTTGCCAACCTCTTCTCCATGAGGTCA
TTCATAAAGATTGAGGAAGACACATGGCAGAAATACTACTTGGAAGGAGTCTCAAATGAA
ATGTACACAGAATATCTCTCCAGTGCCTTCGTGGGTCTGTCCTTCCCTACTGTTTGTGAG
CTGTGTTTTGTGAAGCTCAAGCTCCTAATGATAGCCATTGAGTACAAGTCTGCCAACCGA
GAGAGCCGAAGCCGAAAGCGTATATTAATTAATCCTGGAAACCATCTTAAGATCCAAGAA
GGTACTTTAGGATTTTTCATCGCAAGTGATGCCAAAGAAGTTAAAAGGGCATTTTTTTAC
TGCAAGGCCTGTCATGATGACATCACAGATCCCAAAAGAATAAAAAAATGTGGCTGCAAA
CGGCTTGAAGATGAGCAGCCGTCAACACTATCACCAAAAAAAAAGCAACGGAATGGAGGC
ATGCGGAACTCACCCAACACCTCGCCTAAGCTGATGAGGCATGACCCCTTGTTAATTCCT
GGCAATGATCAGATTGACAACATGGACTCCAATGTGAAGAAGTACGACTCTACTGGGATG
TTTCACTGGTGTGCACCCAAGGAGATAGAGAAAGTCATCCTGACTCGAAGTGAAGCTGCC
ATGACCGTCCTGAGTGGCCATGTCGTGGTCTGCATCTTTGGCGACGTCAGCTCAGCCCTG
ATCGGCCTCCGGAACCTGGTGATGCCGCTCCGTGCCAGCAACTTTCATTACCATGAGCTC
AAGCACATTGTGTTTGTGGGCTCTATTGAGTACCTCAAGCGGGAATGGGAGACGCTTCAT
AACTTCCCCAAAGTGTCCATATTGCCTGGTACGCCATTAAGTCGGGCTGATTTAAGGGCT
GTCAACATCAACCTCTGTGACATGTGCGTTATCCTGTCAGCCAATCAGAATAATATTGAT
GATACTTCGCTGCAGGACAAGGAATGCATCTTGGCGTCACTCAACATCAAATCTATGCAG
TTTGATGACAGCATCGGAGTCTTGCAGGCTAATTCCCAAGGGTTCACACCTCCAGGAATG
GATAGATCCTCTCCAGATAACAGCCCAGTGCACGGGATGTTACGTCAACCATCCATCACA
ACTGGGGTCAACATCCCCATCATCACTGAACTAGTGAACGATACTAATGTTCAGTTTTTG
GACCAAGACGATGATGATGACCCTGATACAGAACTGTACCTCACGCAGCCCTTTGCCTGT
GGGACAGCATTTGCCGTCAGTGTCCTGGACTCACTCATGAGCGCGACGTACTTCAATGAC
AATATCCTCACCCTGATACGGACCCTGGTGACCGGAGGAGCCACGCCGGAGCTGGAGGCT
CTGATTGCTGAGGAAAACGCCCTTAGAGGTGGCTACAGCACCCCGCAGACACTGGCCAAT
AGGGACCGCTGCCGCGTGGCCCAGTTAGCTCTGCTCGATGGGCCATTTGCGGACTTAGGG
GATGGTGGTTGTTATGGTGATCTGTTCTGCAAAGCTCTGAAAACATATAATATGCTTTGT
TTTGGAATTTACCGGCTGAGAGATGCTCACCTCAGCACCCCCAGTCAGTGCACAAAGAGG
TATGTCATCACCAACCCGCCCTATGAGTTTGAGCTCGTGCCGACGGACCTGATCTTCTGC
TTAATGCAGTTTGACCACAATGCCGGCCAGTCCCGGGCCAGCCTGTCCCATTCCTCCCAC
TCGTCGCAGTCCTCCAGCAAGAAGAGCTCCTCTGTTCACTCCATCCCATCCACAGCAAAC
CGACAGAACCGGCCCAAGTCCAGGGAGTCCCGGGACAAACAGAACAGAAAAGAAATGGTT
TACAGATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00520</identifier>
            <name>Ion_trans</name>
          </pfam>
          <pfam>
            <identifier>PF03493</identifier>
            <name>BK_channel_a</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>apical plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>caveola</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>external side of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>terminal bouton</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>voltage-gated potassium channel complex</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>actin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>calcium-activated potassium channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>large conductance calcium-activated potassium channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>voltage-gated potassium channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>adult walking behavior</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>auditory receptor cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>blood coagulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell maturation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular potassium ion homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>eye blink reflex</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>locomotor rhythm</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>micturition</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell volume</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neuromuscular process controlling balance</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neuronal action potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>potassium ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>potassium ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein homooligomerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of aldosterone metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of membrane potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>relaxation of vascular smooth muscle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to calcium ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to carbon monoxide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to hypoxia</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to osmotic stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>saliva secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sensory perception of sound</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>smooth muscle contraction involved in micturition</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001191</id>
      <name>Protein S100-P</name>
      <organism>Humans</organism>
      <actions>
        <action>antagonist</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A12256</ref-id>
            <pubmed-id>17179482</pubmed-id>
            <citation>Arumugam T, Ramachandran V, Logsdon CD: Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst. 2006 Dec 20;98(24):1806-18.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P25815" source="Swiss-Prot">
        <name>Protein S100-P</name>
        <general-function>Magnesium ion binding</general-function>
        <specific-function>May function as calcium sensor and contribute to cellular calcium signaling. In a calcium-dependent manner, functions by interacting with other proteins, such as EZR and PPP5C, and indirectly plays a role in physiological processes like the formation of microvilli in epithelial cells. May stimulate cell proliferation in an autocrine manner via activation of the receptor for activated glycation end products (RAGE).</specific-function>
        <gene-name>S100P</gene-name>
        <locus>4p16</locus>
        <cellular-location>Nucleus</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.5</theoretical-pi>
        <molecular-weight>10399.81</molecular-weight>
        <chromosome-location>4</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:10504</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>S100P</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X65614</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>36178</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P25815</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>S100P_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>MIG9</synonym>
          <synonym>Migration-inducing gene 9 protein</synonym>
          <synonym>Protein S100-E</synonym>
          <synonym>S100 calcium-binding protein P</synonym>
          <synonym>S100E</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002369|Protein S100-P
MTELETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKD
LDANGDAQVDFSEFIVFVAAITSACHKYFEKAGLK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010829|Protein S100-P (S100P)
ATGACGGAACTAGAGACAGCCATGGGCATGATCATAGACGTCTTTTCCCGATATTCGGGC
AGCGAGGGCAGCACGCAGACCCTGACCAAGGGGGAGCTCAAGGTGCTGATGGAGAAGGAG
CTACCAGGCTTCCTGCAGAGTGGAAAAGACAAGGATGCCGTGGATAAATTGCTCAAGGAC
CTGGACGCCAATGGAGATGCCCAGGTGGACTTCAGTGAGTTCATCGTGTTCGTGGCTGCA
ATCACGTCTGCCTGTCACAAGTACTTTGAGAAGGCAGGACTCAAATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01023</identifier>
            <name>S_100</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>microvillus membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>calcium ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>calcium-dependent protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>magnesium ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>endothelial cell migration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to organic substance</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>